133 related articles for article (PubMed ID: 11284777)
1. Comparative efficacy of new investigational agents against Helicobacter pylori.
Osato MS; Reddy SG; Piergies AA; Bochenek WJ; Testa RT; Graham DY
Aliment Pharmacol Ther; 2001 Apr; 15(4):487-92. PubMed ID: 11284777
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori.
Osato MS; Reddy R; Reddy SG; Penland RL; Graham DY
Int J Antimicrob Agents; 2001 Jan; 17(1):39-44. PubMed ID: 11137647
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
[TBL] [Abstract][Full Text] [Related]
4. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
Malanoski GJ; Eliopoulos GM; Ferraro MJ; Moellering RC
Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):131-3. PubMed ID: 8388791
[TBL] [Abstract][Full Text] [Related]
5. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori.
Grignon B; Tankovic J; Mégraud F; Glupczynski Y; Husson MO; Conroy MC; Emond JP; Loulergue J; Raymond J; Fauchère JL
Microb Drug Resist; 2002; 8(1):61-6. PubMed ID: 12002651
[TBL] [Abstract][Full Text] [Related]
6. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.
Pandya HB; Agravat HH; Patel JS; Sodagar NR
Indian J Med Microbiol; 2014; 32(4):408-13. PubMed ID: 25297026
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L
Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.
Xia HX; Buckley M; Keane CT; O'Morain CA
J Antimicrob Chemother; 1996 Mar; 37(3):473-81. PubMed ID: 9182104
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of Helicobacter pylori strains isolated from Iranian children: High frequency of A2143G point mutation associated with clarithromycin resistance.
Mahmoudi S; Mamishi S; Banar M; Keshavarz Valian S; Bahador A; Najafi M; Farahmand F; Pourakbari B
J Glob Antimicrob Resist; 2017 Sep; 10():131-135. PubMed ID: 28720314
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Helicobacter pylori susceptibility to rifaximin].
Quesada M; Sanfeliu I; Junquera F; Segura F; Calvet X
Gastroenterol Hepatol; 2004; 27(7):393-6. PubMed ID: 15461936
[TBL] [Abstract][Full Text] [Related]
13. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
Tanih NF; Okeleye BI; Naidoo N; Clarke AM; Mkwetshana N; Green E; Ndip LM; Ndip RN
S Afr Med J; 2010 Jan; 100(1):49-52. PubMed ID: 20429489
[TBL] [Abstract][Full Text] [Related]
14. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.
McMahon BJ; Hennessy TW; Bensler JM; Bruden DL; Parkinson AJ; Morris JM; Reasonover AL; Hurlburt DA; Bruce MG; Sacco F; Butler JC
Ann Intern Med; 2003 Sep; 139(6):463-9. PubMed ID: 13679322
[TBL] [Abstract][Full Text] [Related]
15. [Drug susceptibility of clinically isolated Helicobacter pylori].
Nakae M; Sugahara Y; Sasaki H; Yasui H; Imai C; Hasegawa Y; Osaka K; Shibasaki K
Jpn J Antibiot; 1998 Apr; 51(4):281-5. PubMed ID: 9644601
[TBL] [Abstract][Full Text] [Related]
16. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
[TBL] [Abstract][Full Text] [Related]
17. Effect of biofilm formation by clinical isolates of
Attaran B; Falsafi T; Ghorbanmehr N
World J Gastroenterol; 2017 Feb; 23(7):1163-1170. PubMed ID: 28275296
[TBL] [Abstract][Full Text] [Related]
18. A new semi-solid agar dilution method for determining amoxycillin, clarithromycin and azithromycin MICs for Helicobacter pylori isolates.
Kobayashi I; Hasegawa M; Saika T; Nishida M; Fujioka T; Nasu M
J Antimicrob Chemother; 1997 Nov; 40(5):713-6. PubMed ID: 9421321
[TBL] [Abstract][Full Text] [Related]
19. In vitro exposure to macrolide antibiotics in Helicobacter pylori strains isolated from children.
Fujimura S; Kato S; Iinuma K; Watanabe A
J Infect Chemother; 2004 Apr; 10(2):128-30. PubMed ID: 15160309
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
